EMPLOYMENT AGREEMENT FOR AMIR AVNIELEmployment Agreement • February 27th, 2017 • AIT Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledFebruary 27th, 2017 Company Industry Jurisdiction
AGREEMENTChairman Appointment Agreement • February 27th, 2017 • AIT Therapeutics, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledFebruary 27th, 2017 Company IndustryThis agreement (the “Agreement”) is entered into as of the 3rd day of August, 2015 (the “Effective Date”) by and between Advanced Inhalation Therapies (AIT) Ltd., an Israeli corporation (“AIT”), and Ron Bentsur (“Bentsur”).
CSO AGREEMENTCso Agreement • February 27th, 2017 • AIT Therapeutics, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledFebruary 27th, 2017 Company IndustryTHIS AGREEMENT (the “Agreement”) is entered into as of December __, 2012, with effect from _______ 2012 (the “Effective Date”) by and between Advanced Inhalation Therapies (AIT) Ltd., a private Israeli Company No. 51-460938-7, having its principal office at 7 Imbar St. box # 3542, Petah Tiqwa 49511 Israel (the “Company”), and Dr. Yossef Av-Gay, a university professor residing at 3849 West 13th Ave., Vancouver, B.C. Canada (the “Consultant”).
SERVICE AGREEMENTService Agreement • February 27th, 2017 • AIT Therapeutics, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledFebruary 27th, 2017 Company IndustryThis Service Agreement (the "Agreement") is entered into as of October first, 2014 between Advanced Inhalation Therapies (AIT) Ltd., a company organized and currently existing under the laws of the State of Israel, of 2 Meir Weisgal Rd., Rehovot, 7632605 Israel, (the "Company"), Dandelion Investments Ltd., of Nordeo 19 Rishon Lezion (the "Service Provider").
AMENDMENT TO CSO AGREEMENTCso Agreement • February 27th, 2017 • AIT Therapeutics, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledFebruary 27th, 2017 Company IndustryThis Amendment to the CSO Agreement (the “Amendment”) is made as of October 21, 2014, by and between Advanced Inhalation Therapies (AIT) Ltd., a private Israeli Company No. 51‑460938-7, having its principal office at 2 Meir Weisgal Road, Rehovot, Israel (the “Company”), and Prof. Yossef Av-Gay, residing at 3849 West 13th Ave., Vancouver, B.C, Canada (the “Consultant”). Unless otherwise specified herein, capitalized terms shall have the meaning ascribed to them in the Original Agreement (as defined below).